Publications by authors named "Sobiecka M"

Hypersensitivity pneumonitis (HP) is an interstitial inflammatory lung disease that develops as a result of exposition to various, mostly organic antigens. In some patients, fibrotic HP is diagnosed. Factors predisposing to the development of fibrotic lung disease in HP patients are not well documented in the literature.

View Article and Find Full Text PDF
Article Synopsis
  • Sarcoidosis-associated pulmonary hypertension (SAPH) is classified as Group 5 pulmonary hypertension and often develops from advanced lung fibrosis, but about 30% of patients show no significant fibrosis, indicating other causes like vascular lesions.
  • A case study of a 69-year-old woman highlighted that her SAPH resulted from pulmonary artery stenosis due to enlarged lymph nodes, despite lacking thrombi.
  • Effective early detection strategies for pulmonary hypertension in sarcoidosis patients are necessary, as well as identifying the specific phenotype of the condition to guide treatment.
View Article and Find Full Text PDF

The onset of the COVID-19 pandemic allowed physicians to gain experience in lung ultrasound (LUS) during the acute phase of the disease. However, limited data are available on LUS findings during the recovery phase. The aim of this study was to evaluate the utility of LUS to assess lung involvement in patients with post-COVID-19 syndrome.

View Article and Find Full Text PDF

Background: Granulomatosis with polyangiitis (GPA) is characterized by necrotizing granulomatous inflammation with necrotizing vasculitis predominantly affecting small to medium vessels. The survival rates have drastically improved; however, GPA can be lethal, with older patients having a worse prognosis and higher mortality than younger patients. Moreover, the incidence of various cancers has been reported to increase in patients with GPA.

View Article and Find Full Text PDF

Background: The importance of D-dimers (DD) assessment in the diagnostic algorithm of venous thromboembolic (VTE) disease is well known. Increase of DD concentration may be also associated with neoplastic disease. Many studies documented that high concentration of DD before solid tumour surgery indicates more advanced disease and poor life expectancy.

View Article and Find Full Text PDF

Sarcoidosis is a systemic, granulomatous disease of unknown etiology, most often manifested by mediastinal and hilar lymph node enlargement and parenchymal nodules in the lungs. However, it may involve any other organ. Neuro-sarcoidosis, a condition that affects up to 20% of sarcoidosis patients, can be found in any part of the central or peripheral nervous system and has important ophthalmic and neuro-ophthalmic manifestations.

View Article and Find Full Text PDF
Article Synopsis
  • Nintedanib is used to treat idiopathic pulmonary fibrosis (IPF) and this study analyzed its safety and efficacy in a large group of Polish patients from March 2018 to October 2021.* -
  • The study included 501 patients, mostly male and averaging around 71 years old, who were monitored for a median of 15 months; results showed stable pulmonary function for most, although some experienced adverse drug reactions (ADRs) like diarrhea and decreased appetite.* -
  • Overall, nintedanib was found to be safe with acceptable side effects, and the findings align with previous research on nintedanib's effectiveness in managing IPF.*
View Article and Find Full Text PDF

Hypersensitivity pneumonitis (HP) is an exposure-related interstitial lung disease with two phenotypes-fibrotic and non-fibrotic. Genetic predisposition is an important factor in the disease pathogenesis and fibrosis development. Several genes are supposed to be associated with the fibrosing cascade in the lungs.

View Article and Find Full Text PDF

A Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) causing coronavirus disease 2019 (COVID-19) led to a pandemic outbreak in 2019. COVID-19's course and its treatment in immunocompromised patients are uncertain. Furthermore, there is a possibility of protracted SARS-CoV-2 infection and the need for repeated antiviral treatment.

View Article and Find Full Text PDF

Unlabelled: The six-minute-walking test (6MWT) is an easy-to-perform, cheap and valuable tool to assess the physical performance of patients. It has been used as one of the endpoints in many clinical trials investigating treatment efficacy in pulmonary arterial hypertension and idiopathic pulmonary fibrosis. However, the utility of 6MWT in patients diagnosed with hypersensitivity pneumonitis (HP) is still under investigation.

View Article and Find Full Text PDF

Background: Fibrotic hypersensitivity pneumonitis (fHP) shares many features with other fibrotic interstitial lung diseases (ILD), and as a result it can be misdiagnosed as idiopathic pulmonary fibrosis (IPF). We aimed to determine the value of bronchoalveolar lavage (BAL) total cell count (TCC) and lymphocytosis in distinguishing fHP and IPF and to evaluate the best cut-off points discriminating these two fibrotic ILD.

Methods: A retrospective cohort study of fHP and IPF patients diagnosed between 2005 and 2018 was conducted.

View Article and Find Full Text PDF

Purulent pericarditis (PP) is rare disease, and if left untreated, it is associated with very high mortality, nearly 100%. A considerable clinical problem due to PP is a very high probability of developing constrictive pericarditis (CP). Pericardial drainage is essential in the treatment of PP and should be performed urgently.

View Article and Find Full Text PDF

Hypersensitivity pneumonitis (HP) is one of the interstitial lung diseases with clearly established diagnostic criteria. Nevertheless, pharmacologic treatment recommendations are still lacking. Most specialists use steroids as first-line drugs, sometimes combined with an immunosuppressive agent.

View Article and Find Full Text PDF
Article Synopsis
  • * Accurate diagnosis of underlying diseases, particularly autoimmune conditions, is critical, and serological testing should be routinely conducted.
  • * For treatment, nintedanib is favored over pirfenidone for underlying diseases not responding to standard therapies, and simultaneous use of immunomodulatory and antifibrotic drugs is permissible, with a focus on holistic care including non-pharmacological approaches and eligibility for lung transplantation.
View Article and Find Full Text PDF

For over two years, the world has been facing the epidemiological and health challenge of the coronavirus disease 2019 (COVID-19) pandemic, caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. Growing problems are also complications after the development of COVID-19 in the form of post and long- COVID syndromes, posing a challenge for the medical community, both for clinicians and the scientific world. SARS-CoV-2 infection is associated with an increased risk of cardiovascular complications, especially thromboembolic complications, which are associated with both thrombosis of small and very small vessels due to immunothrombosis, and the development of venous thromboembolism.

View Article and Find Full Text PDF

Background: Pirfenidone and nintedanib are considered as the standard of care in idiopathic pulmonary fibrosis (IPF), but there is no consensus as to which of these two agents should be regarded as first-line treatment.

Objective: To provide real-world data on therapeutic decisions of pulmonary specialists, particularly the choice of the antifibrotic drug in patients with IPF.

Methods: This was a multicenter, prospective survey collecting clinical data of patients with IPF considered as candidates for antifibrotic treatment between September 2019 and December 2020.

View Article and Find Full Text PDF

is a slow-growing, nontuberculous mycobacterium (NTM) belonging to the (). It was identified as a unique species in 2004. Since 2013 it has been reported as a cause of disseminated infection in patients after cardiac surgeries.

View Article and Find Full Text PDF

Background: Idiopathic pulmonary fibrosis (IPF) and chronic hypersensitivity pneumonitis share commonalities in pathogenesis shifting haemostasis balance towards the procoagulant and antifibrinolytic activity. Several studies have suggested an increased risk of venous thromboembolism in IPF. The association between venous thromboembolism and chronic hypersensitivity pneumonitis has not been studied yet.

View Article and Find Full Text PDF

Background: Amyloidosis is an uncommon condition, which results from accumulation of misfolded extracellular insoluble protein in tissues and organs of the body, causing its damage and dysfunction. Histologically, after staining with Congo red, the amyloid deposits show an apple-green birefringence under polarized light microscope. Amyloidosis can affect all organ systems and is classified into hereditary or acquired, localized or systemic.

View Article and Find Full Text PDF

Actinomycosis is a rare disease caused by Actinomyces spp. The clinical and radiological picture of the disease is uncharacter-istic, which delays the diagnosis and can lead to complications. We present a case of pulmonary actinomycosis complicated by a chest wall fistula in a 43-year-old man with advanced tooth decay.

View Article and Find Full Text PDF

The -Diels-Alder reactions of in situ-generated azoalkenes with thioketones were shown to offer a straightforward method for an efficient and regioselective synthesis of scarcely known N-substituted 1,3,4-thiadiazine derivatives. The scope of the method was fairly broad, allowing the use of a series of aryl-, ferrocenyl-, and alkyl-substituted thioketones. However, in the case of N-tosyl-substituted cycloadducts derived from 1-thioxo-2,2,4,4-tetramethylcyclobutan-3-one and the structurally analogous 1,3-dithione, a more complicated pathway was observed.

View Article and Find Full Text PDF
Article Synopsis
  • Pirfenidone, an antifibrotic medication, has been used in Poland since 2017 to treat idiopathic pulmonary fibrosis (IPF), with the PolExPIR study analyzing its real-world safety and efficacy among Polish patients from January 2017 to September 2019.
  • The study identified 307 patients, with an average age of nearly 69 years, and found that many required dose adjustments; approximately 46% discontinued treatment due to various reasons, including adverse drug reactions and disease progression.
  • Overall, patients showed stable pulmonary function during the study, but there was a notable decline in lung capacity over two years, with a 10.75% mortality rate among participants.
View Article and Find Full Text PDF

Introduction: Pulmonary hypertension (PH) is a well-recognised complication of interstitial lung diseases (ILD), which worsens prognosis and impairs exercise capacity. Echocardiography is the most widely used, non-invasive method for PH assessment. The aim of our study was to identify the factors predictive for echocardiographic signs of PH in newly recognised ILD patients.

View Article and Find Full Text PDF
Article Synopsis
  • The Polish Respiratory Society has created guidelines for diagnosing and treating idiopathic pulmonary fibrosis (IPF), based on input from experts and current literature.
  • It includes 28 recommendations covering diagnosis, pharmacological treatment, and non-pharmacological/palliative care approaches.
  • The guidelines emphasize avoiding surgical lung biopsy in specific cases, recommend antifibrotic medications regardless of functional impairment, and advocate for pulmonary rehabilitation and other support therapies for IPF patients.
View Article and Find Full Text PDF

Lipoid pneumonia is a rare pulmonary disease, classified in terms of the source of lipid exposure into two variants: exogenous and endogenous. We present a patient with exogenous lipoid pneumonia, acquired after chronic exposure to paraffin oil-containing nasal drops. The diagnosis was established by demonstration of lipid-laden macrophages in bronchoalveolar lavage, chest computed tomography results and a history of lipid exposure.

View Article and Find Full Text PDF